Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study - Summary - MDSpire
Advertisement
Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study
To explore the clinical characteristics and independent risk factors of pulmonary consolidation among children with Mycoplasma pneumoniae pneumonia carrying the 23S rRNA A2063G mutation, highlighting the significance of these factors in clinical outcomes.
Key Findings:
347 children were included in the study.
Children with the A2063G mutation were older and had higher rates of pre-admission cough and pulmonary consolidation.
Mutation-positive children had elevated levels of globulin, NLR, MLR, PLR, PIV, and SII, and lower levels of lymphocytes and albumin (all P < 0.05).
In the A2063G group, those with pulmonary consolidation had longer fever duration, higher maximum body temperature, and longer hospital stays (all P < 0.05).
Age and albumin levels were identified as independent risk factors for pulmonary consolidation (OR = 1.010 and 0.875, respectively; both P < 0.05).
Interpretation:
Older age and lower albumin levels are associated with a higher risk of pulmonary consolidation in children with A2063G-mutant Mycoplasma pneumoniae pneumonia, suggesting that an enhanced inflammatory immune response may contribute to this complication, which has important implications for clinical management.
Limitations:
The study is retrospective and conducted at a single center, which may limit generalizability.
Potential selection and information biases inherent in retrospective studies, as well as unmeasured confounding factors.
Conclusion:
Identifying older age and lower albumin levels as risk factors can aid in early risk assessment and individualized treatment for children with A2063G-mutant Mycoplasma pneumoniae pneumonia, emphasizing the need for proactive clinical strategies.
